Dayra Therapeutics manufactures peptide based medicines.
Dayra Therapeutics has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Dayra Therapeutics's investors include Versant Ventures.
Dayra Therapeutics is headquartered in Cambridge, United States.
Dayra Therapeutics manufactures peptide based medicines.
Dayra Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Dayra Therapeutics — Funding & Investors." VCBacked, November 24, 2025, https://www.vcbacked.co/company/dayra-therapeutics. Accessed November 11, 2026.
VCBacked. (2025). Dayra Therapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/dayra-therapeutics
{{cite web |title=Dayra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dayra-therapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Dayra Therapeutics? Request a listing update